From: Identify glioma recurrence and treatment effects with triple-tracer PET/CT
Characteristics | TuR | TrE | Â | P values |
---|---|---|---|---|
N | 34 | 9 | Â | Â |
Gender | Â | Â | Â | Â |
Male | 25 | 2 | X2 = 8.02 | 0.02* |
Female | 9 | 7 | Â | Â |
Age (years) | 41.12 ± 12.52 | 44.11 ± 13.91 | t = 0.62 | 0.54 |
WHO grade | Â | Â | Â | Â |
II | 10 | 2 | Â | Â |
III | 10 | 6 | X2 = 4.63 | 0.09 |
IV | 14 | 1 | Â | Â |
IDH1 | Â | Â | Â | Â |
Mutation | 16 | 8 | X2 = 5.53 | 0.03* |
Wide type | 13 | 0 | Â | Â |
Dose of RT (Gy) | 59.41 ± 1.81 | 58.78 ± 1.99 | t = -0.92 | 0.37 |
interval from RT (Mon.) | 22.51 ± 21.05 | 29.61 ± 16.61 | t = 0.93 | 0.36 |
interval from First Diagnosis (Mon.) | 25.29 ± 21.28 | 32.03 ± 16.57 | t = 0.88 | 0.39 |